Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms

por Dobrovolny, Hana M., Beauchemin, Catherine A. A.
Publicado 2017

Duration of SHIV production by infected cells is not exponentially distributed: Implications for estimates of infection parameters and antiviral efficacy

por Beauchemin, Catherine A. A., Miura, Tomoyuki, Iwami, Shingo
Publicado 2017

Agent-based modeling of host–pathogen systems: The successes and challenges

por Bauer, Amy L., Beauchemin, Catherine A.A., Perelson, Alan S.
Publicado 2009

(In)validating experimentally derived knowledge about influenza A defective interfering particles

por Liao, Laura E., Iwami, Shingo, Beauchemin, Catherine A. A.
Publicado 2016

The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients

por Palmer, John, Dobrovolny, Hana M., Beauchemin, Catherine A. A.
Publicado 2017

Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors

por Liao, Laura E., Kowal, Szymon, Cardenas, Daniel A., Beauchemin, Catherine A. A.
Publicado 2017

A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract

por Quirouette, Christian, Younis, Nada P., Reddy, Micaela B., Beauchemin, Catherine A. A.
Publicado 2020

Correction: A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract

por Quirouette, Christian, Younis, Nada P., Reddy, Micaela B., Beauchemin, Catherine A. A.
Publicado 2020

Correction: A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract

por Quirouette, Christian, Younis, Nada P., Reddy, Micaela B., Beauchemin, Catherine A. A.
Publicado 2022

Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses

por Beauchemin, Catherine A. A., Kim, Young-In, Yu, Qin, Ciaramella, Giuseppe, DeVincenzo, John P.
Publicado 2019

The effect of random virus failure following cell entry on infection outcome and the success of antiviral therapy

por Quirouette, Christian, Cresta, Daniel, Li, Jizhou, Wilkie, Kathleen P., Liang, Haozhao, Beauchemin, Catherine A. A.
Publicado 2023

Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response

por Dobrovolny, Hana M., Reddy, Micaela B., Kamal, Mohamed A., Rayner, Craig R., Beauchemin, Catherine A. A.
Publicado 2013

Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility

por Paradis, Eric G., Pinilla, Lady Tatiana, Holder, Benjamin P., Abed, Yacine, Boivin, Guy, Beauchemin, Catherine A.A.
Publicado 2015

Exploring Cell Tropism as a Possible Contributor to Influenza Infection Severity

por Dobrovolny, Hana M., Baron, Marc J., Gieschke, Ronald, Davies, Brian E., Jumbe, Nelson L., Beauchemin, Catherine A. A.
Publicado 2010

Assessing the In Vitro Fitness of an Oseltamivir-Resistant Seasonal A/H1N1 Influenza Strain Using a Mathematical Model

por Holder, Benjamin P., Simon, Philippe, Liao, Laura E., Abed, Yacine, Bouhy, Xavier, Beauchemin, Catherine A. A., Boivin, Guy
Publicado 2011

A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain

por Kakizoe, Yusuke, Nakaoka, Shinji, Beauchemin, Catherine A. A., Morita, Satoru, Mori, Hiromi, Igarashi, Tatsuhiko, Aihara, Kazuyuki, Miura, Tomoyuki, Iwami, Shingo
Publicado 2015

Time to revisit the endpoint dilution assay and to replace the TCID(50) as a measure of a virus sample’s infection concentration

por Cresta, Daniel, Warren, Donald C., Quirouette, Christian, Smith, Amanda P., Lane, Lindey C., Smith, Amber M., Beauchemin, Catherine A. A.
Publicado 2021

Correction: Time to revisit the endpoint dilution assay and to replace the TCID(50) as a measure of a virus sample’s infection concentration

por Cresta, Daniel, Warren, Donald C., Quirouette, Christian, Smith, Amanda P., Lane, Lindey C., Smith, Amber M., Beauchemin, Catherine A. A.
Publicado 2023

Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses

por Simon, Philippe F., de La Vega, Marc-Antoine, Paradis, Éric, Mendoza, Emelissa, Coombs, Kevin M., Kobasa, Darwyn, Beauchemin, Catherine A. A.
Publicado 2016

Utility of Human In Vitro Data in Risk Assessments of Influenza A Virus Using the Ferret Model

por Creager, Hannah M., Kieran, Troy J., Zeng, Hui, Sun, Xiangjie, Pulit-Penaloza, Joanna A., Holmes, Katie E., Johnson, Anders F., Tumpey, Terrence M., Maines, Taronna R., Beauchemin, Catherine A. A., Belser, Jessica A.
Publicado 2023